Chromic picolinate treatment

• US 5,087,624 A
• Filed: 07/13/1990
• Issued: 02/11/1992
• Est. Priority Date: 03/21/1989
• Status: Expired due to Term

• Current Assignee: Nutrition21 LLC
• Original Assignee: Nutrition21 LLC
• Inventors: Boynton, Herb, Evans, Gary W.
• Primary Examiner(s): Waddell, Frederick E.
• Assistant Examiner(s): HENLEY III, RAYMOND J
• Application Number:
  US07/553,184
• Time in Patent Office: 578 Days
• Field of Search: 514/505, 514/188
• US Class Current: 514/188
• CPC Class Codes: A61K 31/555 containing heavy metals, e.g. hemin, hematin, melarsoprol

Abstract

The administration of chromic picolinate, preferably in the form of chromic tripicolinate, as a prophylactic or therapeutic agent for controlling various blood serum parameters. In particular, the administration is for controlling blood serum lipid levels, including the lowering of undesirably high blood serum LDL-cholesterol levels and the raising of blood serum HDL-cholesterol levels. Additionally, the administration is for controlling undesirable high blood serum glucose levels, this being particularly applicable for the treatment of maturity-onset diabetes. Additionally, chromic picolinate, preferably in the form of chromic tripicolinate, is administered to facilitate uptake of amino acids by skeletal muscle. Thus chromic picolinate can act as an effective anabolic agent.

Claims

1. A method for increasing the lean body mass of a mammal in need of such increase, comprising administering to said mammal an effective, lean-body-mass increasing amount of a composition consisting essentially of chromic tripicolinate.

5. A method as defined in any one of claims 1 to 4, wherein the mammal is a human.

2. A method for increasing the lean body mass of a mammal in need of such increase, comprising:

(a) administering an effective lean-body-mass increasing amount of chromic tripicolinate on each of a plurality of days; and

(b) then measuring the lean body mass;

the administration of chromic tripicolinate being continued until an increase in lean body mass is measured.

3. The method of claim 2 wherein at least about 200 μ

g of chromium as chromic tripicolinate is administered each day for a plurality of days.

4. The method of claim 2 wherein at least about 1000 μ

g of chromic tripicolinate is administered each day for a plurality of days.

8. The method of claim 2 or 7 wherein the administration of chromic tripicolinate is continued until the proportion of body mass which is lean body mass, has increased.

6. A method for increasing the lean body mass of a mammal in need of such increase, comprising administering to said mammal an effective, lean-body-mass increasing amount of chromic tripicolinate.

7. A method for increasing the lean body mass of a mammal in need of such increase, comprising:

(a) administering an effective lean-body-mass increasing amount of chromic tripicolinate on each of a plurality of days over a time period during which the human engages in an exercise regimen;

(b) measuring the lean body mass; and

(c) repeating (a) and (b) a plurality of times until an increased lean body mass resulting from chromic tripicolinate administration is measured.

9. A method for increasing the lean body mass of a mammal in need of such increase, comprising:

(a) administering an effective lean-body-mass increasing amount of a composition having a chromium ion-containing compound and a picolinate-containing compound, combined in a manner such that the two can form chromic tripicolinate in the human, on each of a plurality of days over a time period during which the human engages in an exercise regimen;

(b) measuring the lean body mass; and

(c) repeating (a) and (b) a plurality of times until an increased lean body mass resulting from administration of the composition is measured.

10. A method for increasing the lean body mass in a human in need of such increase, comprising administering an effective lean-body-mass increasing amount of chromic tripicolinate on each of a plurality of days in which the human engages in an exercise regimen.

11. A method for increasing the lean body mass in a non-human insulin-producing animal in need of such increase, comprising administering to said animal an effective lean-body-mass increasing amount of chromic tripicolinate.

12. A method for increasing the lean body mass in a human in need of such increase, comprising administering to said human an effective lean-body-mass increasing amount of chromic picolinate.

13. A method for reducing the percentage of body fat of a mammal in need of such reduction, comprising administering to said mammal an effective body-fat-reducing amount of chromic tripicolinate.